Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 2
2004 12
2005 10
2006 11
2007 4
2008 14
2009 19
2010 9
2011 17
2012 26
2013 23
2014 15
2015 22
2016 24
2017 18
2018 26
2019 25
2020 19
2021 28
2022 37
2023 28
2024 28
2025 31
2026 29

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

421 results

Results by year

Filters applied: . Clear all
Page 1
European Society of Cardiology: cardiovascular disease statistics 2021.
Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D, Gale CP, Maggioni AP, Petersen SE, Huculeci R, Kazakiewicz D, de Benito Rubio V, Ignatiuk B, Raisi-Estabragh Z, Pawlak A, Karagiannidis E, Treskes R, Gaita D, Beltrame JF, McConnachie A, Bardinet I, Graham I, Flather M, Elliott P, Mossialos EA, Weidinger F, Achenbach S; Atlas Writing Group, European Society of Cardiology. Timmis A, et al. Eur Heart J. 2022 Feb 22;43(8):716-799. doi: 10.1093/eurheartj/ehab892. Eur Heart J. 2022. PMID: 35016208 Free article.
Tumor microenvironment antigens.
Andersen MH. Andersen MH. Semin Immunopathol. 2023 Mar;45(2):253-264. doi: 10.1007/s00281-022-00966-0. Epub 2022 Sep 29. Semin Immunopathol. 2023. PMID: 36175673 Free PMC article. Review.
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.
Glaviano A, Lau HS, Carter LM, Lee EHC, Lam HY, Okina E, Tan DJJ, Tan W, Ang HL, Carbone D, Yee MY, Shanmugam MK, Huang XZ, Sethi G, Tan TZ, Lim LHK, Huang RY, Ungefroren H, Giovannetti E, Tang DG, Bruno TC, Luo P, Andersen MH, Qian BZ, Ishihara J, Radisky DC, Elias S, Yadav S, Kim M, Robert C, Diana P, Schalper KA, Shi T, Merghoub T, Krebs S, Kusumbe AP, Davids MS, Brown JR, Kumar AP. Glaviano A, et al. Among authors: andersen mh. J Hematol Oncol. 2025 Jan 13;18(1):6. doi: 10.1186/s13045-024-01634-6. J Hematol Oncol. 2025. PMID: 39806516 Free PMC article. Review.
Anti-regulatory T cells.
Andersen MH. Andersen MH. Semin Immunopathol. 2017 Apr;39(3):317-326. doi: 10.1007/s00281-016-0593-x. Epub 2016 Sep 27. Semin Immunopathol. 2017. PMID: 27677755 Review.
Cancer and autoimmunity.
Andersen MH. Andersen MH. Semin Immunopathol. 2017 Apr;39(3):241-243. doi: 10.1007/s00281-016-0617-6. Epub 2017 Mar 27. Semin Immunopathol. 2017. PMID: 28349248 Review. No abstract available.
Arginase-1-specific T cells target and modulate tumor-associated macrophages.
Martinenaite E, Lecoq I, Aaboe-Jørgensen M, Ahmad SM, Perez-Penco M, Glöckner HJ, Chapellier M, Lara de la Torre L, Olsen LR, Rømer AMA, Pedersen AW, Andersen MH. Martinenaite E, et al. Among authors: andersen mh. J Immunother Cancer. 2025 Jan 29;13(1):e009930. doi: 10.1136/jitc-2024-009930. J Immunother Cancer. 2025. PMID: 39880485 Free PMC article.
PD-L1-specific T cells.
Ahmad SM, Borch TH, Hansen M, Andersen MH. Ahmad SM, et al. Among authors: andersen mh. Cancer Immunol Immunother. 2016 Jul;65(7):797-804. doi: 10.1007/s00262-015-1783-4. Epub 2016 Jan 2. Cancer Immunol Immunother. 2016. PMID: 26724936 Free PMC article. Review.
421 results